Powder: -20°C for 3 years | In solvent: -80°C for 1 year
ML261 is a inhibitor of hepatic lipid droplets formation with an IC 50 of 69.7 nM. ML261 has research value in non-alcoholic fatty liver disease (NAFLD) and inflammation.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | 35 days | $ 93.00 | |
5 mg | 35 days | $ 225.00 | |
10 mg | 35 days | $ 394.00 | |
25 mg | 35 days | $ 883.00 |
Description | ML261 is a inhibitor of hepatic lipid droplets formation with an IC 50 of 69.7 nM. ML261 has research value in non-alcoholic fatty liver disease (NAFLD) and inflammation. |
In vitro | ML261, at concentrations ranging from 1 nM to 10 μM over 24 hours, inhibits the formation of hepatic lipid droplets in murine AML-12 cells, as demonstrated in the Cell Viability Assay. The assay, utilizing AML-12 cells and maintaining the same concentration and incubation time parameters, identifies an IC50 value of 69.7 nM for this inhibitory effect [1]. |
Molecular Weight | 406.93 |
Formula | C20H23ClN2O3S |
CAS No. | 902523-58-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
ML261 902523-58-4 inhibitor inhibit